204 related articles for article (PubMed ID: 37014050)
1. Materials engineering strategies for cancer vaccine adjuvant development.
Zhang X; Yang B; Ni Q; Chen X
Chem Soc Rev; 2023 May; 52(9):2886-2910. PubMed ID: 37014050
[TBL] [Abstract][Full Text] [Related]
2. MnO
Song T; Liao Y; Zuo Q; Liu N; Liu Z
J Mater Chem B; 2022 May; 10(18):3474-3490. PubMed ID: 35403638
[TBL] [Abstract][Full Text] [Related]
3. Polymeric nanoparticles for DNA vaccine-based cancer immunotherapy: a review.
Danaeifar M; Negahdari B; Eslam HM; Zare H; Ghanaat M; Koushali SS; Malekshahi ZV
Biotechnol Lett; 2023 Sep; 45(9):1053-1072. PubMed ID: 37335426
[TBL] [Abstract][Full Text] [Related]
4. Cancer Vaccines: Adjuvant Potency, Importance of Age, Lifestyle, and Treatments.
Cuzzubbo S; Mangsbo S; Nagarajan D; Habra K; Pockley AG; McArdle SEB
Front Immunol; 2020; 11():615240. PubMed ID: 33679703
[TBL] [Abstract][Full Text] [Related]
5. Developments in Vaccine Adjuvants.
Firdaus FZ; Skwarczynski M; Toth I
Methods Mol Biol; 2022; 2412():145-178. PubMed ID: 34918245
[TBL] [Abstract][Full Text] [Related]
6. Cancer vaccine adjuvants--recent clinical progress and future perspectives.
Banday AH; Jeelani S; Hruby VJ
Immunopharmacol Immunotoxicol; 2015 Feb; 37(1):1-11. PubMed ID: 25318595
[TBL] [Abstract][Full Text] [Related]
7. Current Progress and Challenges in the Study of Adjuvants for Oral Vaccines.
Ou B; Yang Y; Lv H; Lin X; Zhang M
BioDrugs; 2023 Mar; 37(2):143-180. PubMed ID: 36607488
[TBL] [Abstract][Full Text] [Related]
8. Nanovaccines for cancer immunotherapy: Focusing on complex formation between adjuvant and antigen.
Hashemi Goradel N; Nemati M; Bakhshandeh A; Arashkia A; Negahdari B
Int Immunopharmacol; 2023 Apr; 117():109887. PubMed ID: 36841155
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Vaccines for Cancer Immunotherapy.
Wang J; Mamuti M; Wang H
ACS Biomater Sci Eng; 2020 Nov; 6(11):6036-6052. PubMed ID: 33449675
[TBL] [Abstract][Full Text] [Related]
10. New horizons in adjuvants for vaccine development.
Reed SG; Bertholet S; Coler RN; Friede M
Trends Immunol; 2009 Jan; 30(1):23-32. PubMed ID: 19059004
[TBL] [Abstract][Full Text] [Related]
11. Adjuvants and delivery systems based on polymeric nanoparticles for mucosal vaccines.
Jin Z; Gao S; Cui X; Sun D; Zhao K
Int J Pharm; 2019 Dec; 572():118731. PubMed ID: 31669213
[TBL] [Abstract][Full Text] [Related]
12. Emerging Strategies of Engineering and Tracking Dendritic Cells for Cancer Immunotherapy.
Gao Y; Wang Z; Cui Y; Xu M; Weng L
ACS Appl Bio Mater; 2023 Jan; 6(1):24-43. PubMed ID: 36520013
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic Therapy Combined with Antihypoxic Signaling and CpG Adjuvant as an In Situ Tumor Vaccine Based on Metal-Organic Framework Nanoparticles to Boost Cancer Immunotherapy.
Cai Z; Xin F; Wei Z; Wu M; Lin X; Du X; Chen G; Zhang D; Zhang Z; Liu X; Yao C
Adv Healthc Mater; 2020 Jan; 9(1):e1900996. PubMed ID: 31746153
[TBL] [Abstract][Full Text] [Related]
14. Chitin, chitosan, and glycated chitosan regulate immune responses: the novel adjuvants for cancer vaccine.
Li X; Min M; Du N; Gu Y; Hode T; Naylor M; Chen D; Nordquist RE; Chen WR
Clin Dev Immunol; 2013; 2013():387023. PubMed ID: 23533454
[TBL] [Abstract][Full Text] [Related]
15. Using PAMPs and DAMPs as adjuvants in cancer vaccines.
Sun H; Hu W; Yan Y; Zhang Z; Chen Y; Yao X; Teng L; Wang X; Chai D; Zheng J; Wang G
Hum Vaccin Immunother; 2021 Dec; 17(12):5546-5557. PubMed ID: 34520322
[TBL] [Abstract][Full Text] [Related]
16. Adjuvants for malaria vaccines.
Coler RN; Carter D; Friede M; Reed SG
Parasite Immunol; 2009 Sep; 31(9):520-8. PubMed ID: 19691556
[TBL] [Abstract][Full Text] [Related]
17. Use of adjuvants for immunotherapy.
Circelli L; Tornesello M; Buonaguro FM; Buonaguro L
Hum Vaccin Immunother; 2017 Aug; 13(8):1774-1777. PubMed ID: 28604160
[TBL] [Abstract][Full Text] [Related]
18. Roadmap to next-generation cancer vaccines.
Zheng Y; Zhong Z
J Control Release; 2022 Jul; 347():308-313. PubMed ID: 35561869
[TBL] [Abstract][Full Text] [Related]
19. Development of thermostable vaccine adjuvants.
Qi Y; Fox CB
Expert Rev Vaccines; 2021 May; 20(5):497-517. PubMed ID: 33724133
[TBL] [Abstract][Full Text] [Related]
20. Rational Design of T-Cell- and B-Cell-Based Therapeutic Cancer Vaccines.
Li WH; Su JY; Li YM
Acc Chem Res; 2022 Sep; 55(18):2660-2671. PubMed ID: 36048514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
